The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Disorders of Bone Remodeling
Open accessAbstract
The skeleton provides mechanical support for stature and locomotion, protects vital organs, and controls mineral homeostasis. A healthy skeleton must be maintained by constant bone modeling to carry out these crucial functions throughout life. Bone remodeling involves the removal of old or damaged bone by osteoclasts (bone resorption) and the subsequent replacement of new bone formed by osteoblasts (bone formation). Normal bone remodeling requires a tight coupling of bone resorption to bone formation to guarantee no alteration in bone mass or quality after each remodeling cycle. However, this important physiological process can be derailed by a variety of factors, including menopause-associated hormonal changes, age-related factors, changes in physical activity, drugs, and secondary diseases, which lead to the development of various bone disorders in both women and men. We review the major diseases of bone remodeling, emphasizing our current understanding of the underlying pathophysiological mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“OPG, a soluble receptor also produced by osteoblasts that acts as a decoy receptor and neutralizes RANKL, prevents RANKL from interacting with RANK and consequently inhibits osteoclast proliferation, activity, and survival [73, 74].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Once RANKL binds to its natural receptor, expressed by osteoclast precursor cells, it stimulates osteoclast precursor differentiation to active mature osteoclasts and accelerates bone resorption [73].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [73]
In the citing paper
“Abnormal increase in osteoclast formation and activity leads to some bone diseases such as osteoporosis, where resorption exceeds formation causing decreased bone density and increased bone fractures [105].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [105]
In the citing paper
“In patients with chronic liver disease, the balance between osteoclasts and osteoblasts is affected by liver disease, resulting in BRU imbalance [46,50].”
From Bone diseases in patients with chronic liver disease (2019) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,639
Research works printed but not linked: 11
- McGowen JA, 2004, Bone Health and Osteoporosis: A Report of the Surgeon General, 69
- Raisz LG., 1988, Ciba Found. Symp., 136, 226
- Mundy GR., 1991, Ciba Found. Symp., 157, 137
- Andersen TL, 2009, Br. J. Haematol., 48, 551
- Heaney RP, 1978, J. Lab. Clin. Med., 92, 964
- 10.1210/en.142.6.2205 · DOI · Paper page
- 10.1172/JCI200317215 · DOI · Paper page
- 10.1210/jc.83.12.4257 · DOI
- Peretz A, 1989, J. Rheumatol., 16, 363
- Takata S, 2001, J. Med. Investig., 48, 147
- Block GA, 2006, Clinical Guide to the Basics of Bone and Mineral Metabolism in CKD, 77
Cited by
Sorted by citations
Items 801–900 of 1,000
Choi, Y., Yang, J.-M., & Cho, J. (2022) · Applied Sciences · doi:10.3390/app12178849 · Cited by 7
Chen, Z., Rajamanickam, K. R., Ding, M., Kim, S. K., Park, S.-W., Kim, E., Lee, S., & Lee, T. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00114 · Cited by 7
Abidin, I. Z. Z., Johari, A. N., Yazid, M. D., Ariffin, Z. Z., Dyari, H. R. E., & Ariffin, S. H. Z. (2023) · Pharmaceuticals · doi:10.3390/ph16050708 · Cited by 7
“Bone structures undergo a continuous remodeling process throughout life to provide the optimum function by maintaining the mechanical strength of the bone through calcium homeostasis [11].”
BackgroundAhn, S., Baek, J. M., Cheon, Y., Park, S., Lee, M. S., Oh, J., & Kim, J. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500445 · Cited by 7
Marques, M., Belinha, J., Oliveira, A., Manzanares‐Céspedes, M. C., & Jorge, R. N. (2018) · Engineering Analysis with Boundary Elements · doi:10.1016/j.enganabound.2018.05.007 · Cited by 7
Jeong, B., Oh, S., Lee, M. N., & Koh, J. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.4.267 · Cited by 7
“An imbalance between osteoblast and osteoclast activity results in skeletal abnormalities, such as osteoporosis.[3] Therefore, bone disease drug development has focused on identifying specific regulatory signaling molecules.”
BackgroundMcDonald, G. L. K., Wang, M., Hammond, C. L., & Bergen, D. J. M. (2021) · Biomolecules · doi:10.3390/biom11020277 · Cited by 7
“When this balance is perturbed it can lead to various bone remodelling related diseases such as osteopetrosis (excessive bone strength) or osteoporosis (OP; reduced bone strength) [1].”
BackgroundBy inhibiting ADCY5, miR-18a-3p promotes osteoporosis and possibly contributes to spinal fracture
Wang, L., Dong, J., Ma, J., Lu, Q., Shan, B., Han, T., Xie, P., & Zuo, X. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.118 · Cited by 7
Komabashiri, N., Suehiro, F., Ishii, M., & Nishimura, M. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.03.004 · Cited by 7
“In addition, increased IFN-g suppresses osteoclast differentiation [46] and then the imbalance between bone resorption and bone formation leads to abnormal bone remodeling [47].”
BackgroundEwanchuk, B. W., Arnold, C. R., Balce, D. R., Premnath, P., Orsetti, T. L., Warren, A. L., Olsen, A., Krawetz, R. J., & Yates, R. M. (2021) · Science Advances · doi:10.1126/sciadv.abd3684 · Cited by 7
“While the mesenchymal stem cell–derived osteoblasts synthesize new bone, the myeloid-derived osteoclasts are ultimately responsible for the resorption of bone (1).”
BackgroundIrradiation affects the structural, cellular and molecular components of jawbones
Padala, S. R., Kashyap, B., Dekker, H., Mikkonen, J. J. W., Palander, A., Bravenboer, N., & Kullaa, A. M. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2022.2013568 · Cited by 7
“The physiological process of bone remodeling is based on the interactions not only between these cells but also multiple molecular agents including hormones, growth factors, and cytokines (Feng and McDonald 2011).”
BackgroundHong, R., Xie, J., Zhang, F., Pan, H., & Guo, C.-J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28649 · Cited by 7
“As a progressive and systemic bone disease, osteoporosis (OP), is characterized by significant microarchitectural deterioration of the bone tissue and remarkable deduction of bone mineral density (BMD), is common in the aged people from both developing and developed countries.(1) The disorder is clinically classified…”
BackgroundStephan, C. N., Caple, J. M., D’Alonzo, S. S., & Byrd, J. E. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15436 · Cited by 6
“So far, it has not been documented if these same observational patterns apply to males who are known to undergo age-related bone loss at slower rates than females [19, 22 ].”
InfluentialCanonical pathways for validating steroid-associated osteonecrosis in mice
Zheng, L., An, Y., Tong, W., Chen, Z., Wang, Y., Zhang, H., Zhang, S., Chen, X., Liu, W., Wang, X., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117094 · Cited by 6
Tong, X., Fu, X., Gong, A., Yu, G., Chen, N., Chen, B., Gu, J., & Liu, Z. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf033 · Cited by 6
Knockdown of C3aR alleviates age-related bone loss via activation of YAP1/β-catenin signaling
Li, F., & Cui, S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108500 · Cited by 7
“Bone is a dynamic tissue that maintains a balance of bone remodeling through the interregulation of bone formation by osteoblasts and bone resorption by osteo-clasts, which is essential for the ef fi cient and lifelong performance of vital skeletal functions (3, 4).”
The roles of natural killer cells in bone and arthritic disease: a narrative review
Zhao, Y., Liu, Q., Zhao, J.-M., & Song, D. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2506260 · Cited by 6
“Bone remodeling necessitates the meticulous coordination of bone resorption and formation processes to maintain stable bone mass following each renewal cycle [25].”
Bauer, J., Duero, J., & Lindsay, A. D. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00922-5 · Cited by 6
“Under normal circumstances, the cross-talk between osteoclasts, osteoblasts, and osteocytes is balanced such that the rate of new bone formation equals that of old bone resorption [40, 41].”
HMGB1 as an emerging key modulator of bone remodeling: a narrative review
Tang, J., Li, M., & Huang, L. C. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04543-8 · Cited by 7
“…of bone remodeling; Stage 2: bone resorption by osteoclasts and recruitment of bone marrow mesenchymal stem cells (BMSCs) and osteoprogenitors at the same time; Stage 3: osteoblastic differentiation and oste-oid formation; Stage 4: mineralization of osteoid and completion of bone remodeling [3].”
Hamedi, F., Alizadeh, M., & Kheirouri, S. (2025) · Bone · doi:10.1016/j.bone.2025.117622 · Cited by 7
Jia, M., Chen, Z., Zhou, H., Jiang, H., Zhang, Y., Liu, Y., & Wu, M. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214700 · Cited by 6
Zebrafish as a promising model for investigating biological activities of ginseng species—a review
Yu, M., Wang, L., Luo, H., Yang, B., Li, L., Dong, J., Meng, X., Sun, M., & He, M. (2024) · Quality Assurance and Safety of Crops & Foods · doi:10.15586/qas.v16i1.1393 · Cited by 6
From oncogenes to tumor suppressors: The dual role of ncRNAs in fibrosarcoma
Kazmi, I. A., Afzal, M., Almalki, W. H., Renuka Jyothi, S., Alzarea, S. I., Kumar, A., Sinha, A., Kukreti, N., Ali, H., & Abida, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155329 · Cited by 7
Annexin A family: A new perspective on the regulation of bone metabolism
Xu, K., Huang, R., Wen, R., Yao, T., Cao, Y., Chang, B., Cheng, Y., & Yi, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117271 · Cited by 6
Casarrubios, L., Cicuéndez, M., Polo-Montalvo, A., Feito, M. J., Martínez‐del‐Pozo, Á., Arcos, D., Duarte, I. F., & Portolés, M. T. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214085 · Cited by 6
Zou, J., Mi, S., Chen, J., Wusiman, M., Ye, J., Yang, S., Chen, S. X., Huang, Z., Huang, B., Fang, A., et al. (2025) · Nutrients · doi:10.3390/nu17010192 · Cited by 6
“Studies have shown that estrogen deficiency not only affects osteoblasts [32], but also implicates various indirect mechanisms, such as ROS, cytokines, and growth factors [33], leading to accelerated bone conversion and bone loss.”
Iseme, R. A., McEvoy, M., Kelly, B. J., Agnew, L. L., Walker, F. R., Boyle, M., & Attia, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/9407971 · Cited by 6
“Loss of coupling between these two processes leads to osteoporosis, a combination of pathologic bone loss and altered microarchitecture that results in fragility fractures in response to minimal or low velocity force [2, 3].”
BackgroundXu, W. F., Zhu, X., Chen, C., Hu, R., Li, Y., Xu, R., & Li, Z. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86816 · Cited by 6
“Osteoporosis alters bone remodelling by decreasing osteoblast formation and increasing osteoclastic bone reabsorption [5].”
BackgroundPreventive Effects of Chrysanthemum coronarium L. Extract on Bone Metabolism In Vitro and In Vivo
Kim, S. A., Lee, A. S., Hur, H. J., Lee, S. H., & Sung, M. J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6975646 · Cited by 7
Multiscale mechanical responses of young and elderly human femurs: A finite element investigation
Cen, H., Yao, Y., Liu, H., Jia, S., & Gong, H. (2021) · Bone · doi:10.1016/j.bone.2021.116125 · Cited by 6
Osseointegration of Dental Implants and Osteoporosis
Gibreel, S., Mohamed, H. G., Suraj, A. R., & Anil, S. (2021) · Dentistry · doi:10.5772/intechopen.100270 · Cited by 6
Zhu, H., Chen, H., Ding, D., Wang, S., Dai, X., & Zhu, Y. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/2909454 · Cited by 6
RetractedElbeialy, A. A., Bauomi, A. M., Elnaggar, B. M., & Elzomor, H. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01698-1 · Cited by 5
“…cause only osteoporosis and pathological fractures, it can cause also bone erosions, which are shaggy in appearance and distributed in the radiocarpal, radioulnar, metacarpophalangeal and distal interphalangeal joints, in contrast to that which predominate PIP joints of rheumatoid arthritis 24 .”
BackgroundRetractedBarsky, L., Cohen‐Erez, I., Bado, I. L., Zhang, X. H.-F., & Vago, R. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10176-5 · Cited by 6
“balance between bone formation and bone resorption [9, 16].”
BackgroundHu, H., Wang, X., Huang, Y., He, B., Zhu, J., Sun, K., Deng, C., Guo, Y., Hao, D., & Jian, B. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156134 · Cited by 6
Elmorsy, E. M., Al-Ghafari, A. B., & Doghaither, H. A. A. (2023) · Toxicology Research · doi:10.1093/toxres/tfad065 · Cited by 6
BASP1 down-regulates RANKL-induced osteoclastogenesis
Anuj, A., Reuven, N. B., Roberts, S. G. E., & Elson, A. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113758 · Cited by 5
Samani, S. E., & Kaartinen, M. T. (2023) · Cells · doi:10.3390/cells12172139 · Cited by 6
“This renewal process involves the removal of old bone by bone-resorbing cells, osteoclasts, and their replacement with new bone by bone-forming cells, osteoblasts [2].”
BackgroundHe, D., Zheng, S., Cao, J., Deng, J., Ding, R., Xu, Y., & Cheng, X. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09532-3 · Cited by 6
“Throughout life, the coordinated efforts of osteoclast-mediated bone resorption and osteoblast-mediated bone formation maintain a delicate balance, preventing signifi - cant net changes in bone mass or mechanical strength after each remodeling cycle [10, 11].”
Gjørup, H., Kjær, I., Sonnesen, L., Beck‐Nielsen, S. S., & Haubek, D. (2013) · Orthodontics and Craniofacial Research · doi:10.1111/ocr.12028 · Cited by 6
Cathepsin L in Normal and Pathological Bone Remodeling
Leto, G., Crescimanno, M., Flandina, C., Sepporta, M. V., & Tumminello, F. M. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9100-z · Cited by 7
“Osteoporosis (OP) is a skeletal disease characterized by a decrease in bone density and increase in bone fragility due to a persistent excess of bone resorption over bone formation [108].”
BackgroundInfluentialThe Role of Vitamin K in Bone Remodeling and Osteoporosis
Giammanco, M., Majo, D. D., Leto, G., Flandina, C., Piazza, M. D., & Guardia, M. L. (2012) · Journal of Food Research · doi:10.5539/jfr.v1n4p106 · Cited by 6
“It is well known that in subjects older than 30 years, the bone undergoes a physiological reduction (Feng & McDonald, 2011).”
BackgroundInfluentialDharmadas, S., Kumar, H., Pillay, M., Jojo, A., Pj, T., Mangalanandan, T. S., Lakshmanan, V., Pavithran, P. V., & Bal, A. (2020) · PubMed · doi:10.14670/hh-18-162 · Cited by 6
Xie, H., Cao, L., Ye, L., Shan, G., & Song, W. (2021) · Physiology International · doi:10.1556/2060.2020.00042 · Cited by 6
Icariin promotes osteogenic differentiation by upregulating alpha-enolase expression
Xie, D., Xu, Y., Cai, W., Zhuo, J., Zhu, Z., Zhang, H., Zhang, Y., Lan, X., & Yan, H. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101471 · Cited by 6
“Abnormal osteogenesis jeopardises bone homeostasis by inducing an imbalance between bone formation and bone resorption, leading to disorders, such as osteoporosis and osteoarthritis [3,4].”
BackgroundIwaniak, P., Dobrowolski, P., Tomaszewska, E., Hułas‐Stasiak, M., Tomczyk‐Warunek, A., & Gawron, A. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174415007874 · Cited by 6
“Dex as well as other GCs inhibits the synthesis of collagen and proteins, decreasing the production of osteoid in the bone.(36) Collagen fibers, which give cartilage its form and tensile strength,(37) were affected by Dex, whereas in the control group thin and thick collagen fibers were almost equally distributed.”
BackgroundCamargo, G. L., de Souza, R. A., da Silva, D. B., Garcia, J. A. D., & Silveira, L. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.05.017 · Cited by 5
Hatta, N. N. K. N. M., Lokman, M., Mohd Said, N., Daud, A., Ibrahim, M., Sharifudin, M. A., & Deraman, S. (2018) · Enfermería Clínica · doi:10.1016/s1130-8621(18)30074-3 · Cited by 6
MicroRNAs in Bone Diseases: Progress and Prospects
Leong, K.-Y. B., Chan, Y.-H., Abdullah, W. M. A. N. W., Lim, S. E., & Lai, K. (2018) · InTech eBooks · doi:10.5772/intechopen.79275 · Cited by 6
Yang, X., Pande, S., Scott, C., & Friesel, R. E. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28512 · Cited by 6
“Dysregulation of OC differentiation and activation is associated with abnormal bone metabolism and remodeling and contributes to bone diseases.(3,4) In vitro OC differentiation assays have not only advanced our understanding of the biology of OC but also been a useful tool for developing treatments for metabolic bone…”
Background3D Printed Loading Device for Inducing Cellular Mechanotransduction via Matrix Deformation
Truesdell, S. L., George, E. L., Seno, C. E., & Saunders, M. M. (2019) · Experimental Mechanics · doi:10.1007/s11340-019-00531-1 · Cited by 6
“Osteocytes express a variety of surface proteins that are activated by mechanical stretch, including integrins, connexins, and ion channels [5, 6].”
BackgroundPawlak, D., Domaniewski, T., Sieklucka, B., Jakuc, M., & Pawlak, K. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.08.004 · Cited by 6
Hydroxyapatite-based composites for orthopedic drug delivery and tissue engineering
Nayak, A. K., Maity, M., Barik, H., Nanda, S. S., Hasnain, M. S., & Yi, D. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820484-9.00012-x · Cited by 6
Nutrition and Bone Marrow Adiposity in Relation to Bone Health
Dzubanova, M., Beňová, A., Ferenčáková, M., Coupeau, R., & Tencerová, M. (2024) · Physiological Research · doi:10.33549/physiolres.935293 · Cited by 6
Vaquero, M. P., García-Maldonado, E., Gallego‐Narbón, A., Zapatera, B., Alcorta, A., & Martínez-Suárez, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910290 · Cited by 5
“Osteoblasts secrete proteins that are needed for renewing the bone organic matrix, such as type I collagen [4,5].”
BackgroundPark, S., Kim, J., & Ko, J. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01414-3 · Cited by 6
“Osteoporosis is a common bone remodeling disorder 34 .”
Emerging Roles of Eosinophils in Bone
Andreev, D., & Porschitz, P. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00913-6 · Cited by 5
“The highly coordinated character of bone remodeling is illustrated by the fact that almost all new bone formation occurs in areas of previous bone resorption, resulting in a constancy of net bone mass and mechanical strength [28 , 37].”
Cai, W., Jiang, L., Zhao, C., & Zhou, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1576286 · Cited by 5
“MBD include Osteoporosis (OP), Osteomalacia, Mucopolysaccharidosis, Marfan Syndrome, Paget ’ s Disease, and Renal Osteodystrophy, and so on (Feng and McDonald, 2011).”
Chen, Y., Zhang, Z., Ti, H., Wu, J., Yuan, F., & Li, X. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-05944-4 · Cited by 5
“Disruption of this equilibrium, either by increased resorption or decreased formation, leads to progressive bone loss and osteoporosis [62, 63].”
Zhang, Y., Xia, H., Wang, S., Xia, W., Jin, C., Huang, X., Li, K., Wang, S., Zhang, C., Zheng, C., et al. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.02.011 · Cited by 5
Jiang, X., Chen, H., Hou, W., Dai, C., Zhang, R., Chen, E., Zhang, J., Wu, W., Xu, J., Chen, M., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01682-7 · Cited by 5
Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis
Karkache, I. Y., Molstad, D. H. H., Vu, E. K., Jensen, E. D., & Bradley, E. W. (2023) · JBMR Plus · doi:10.1002/jbm4.10806 · Cited by 5
Liu, D., He, C., Liu, Z., Xu, L., Li, J., Zhao, Z., Hu, X., Chen, H., Sun, B., & Wang, Y. (2023) · Cancers · doi:10.3390/cancers15245842 · Cited by 5
Advances in Bone-Targeting Drug Delivery: Emerging Strategies Using Adeno-Associated Virus
Sato, T., Chaugule, S. R., Greenblatt, M. B., Gao, G., & Shim, J. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.034 · Cited by 5
Selenoprotein W engages in overactive osteoclast differentiation in multiple myeloma
Kim, H., Oh, J., Kim, M. K., Lee, K. H., & Jeong, D. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09517-2 · Cited by 6
Chen, L., Zhou, X., Tian, Y., Hu, H., Hong, S., Wu, S., Wei, Z., Wang, K., Li, T., Hua, Z., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106790 · Cited by 5
Wang, L., Liang, L., Zhang, X., Chi, H., & Peng, F. L. (2025) · Scientific Reports · doi:10.1038/s41598-024-82243-8 · Cited by 6
Varela, D., Varela, T., Conceição, N., & Cancela, M. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052069 · Cited by 5
“Despite its seemingly inactive appearance, bone is metabolically dynamic and endures constant remodeling (old or damaged bone is restored by new bone) [2–4].”
Paoletti, N., Lió, P., Merelli, E., & Viceconti, M. (2011) · Computational Methods in Systems Biology · doi:10.1145/2037509.2037536 · Cited by 5
“Hence, the definition of faithful models for BR has a high social and clinical relevance in the prediction of bone diseases [14].”
BackgroundAnti-osteoclastogenic activity of metabolites isolated from Viburnum lutescens Blume
Dang, N. H., Thien, L. D., Minh, N. P., Dung, D. T., Thao, T. P., Lee, J., Kiệm, P. V., & Nhiệm, N. X. (2021) · Phytochemistry Letters · doi:10.1016/j.phytol.2021.07.006 · Cited by 5
Identification of Cellular Voids in the Human Otic Capsule
Hansen, L. J., Bloch, S. L., & Sørensen, M. S. (2021) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-021-00810-6 · Cited by 5
“Bone is a dynamic tissue with a significant turnover (Clarke 2008; Datta et al. 2008; Feng and McDonald 2011) although the static appearance of osteocytes enclosed in lacunae falsely suggests inactivity.”
BackgroundAl-Suhaimi, E. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-9016-7_6 · Cited by 5
Evaluation of vitamin D supplementation intake among children; cross-sectional observational study
Sharafi, N., Fatima, A., Gillani, S. W., AlKaddour, N. A., Banoori, R., Elshafie, R. M., & Rathore, H. A. (2022) · F1000Research · doi:10.12688/f1000research.123373.1 · Cited by 5
Whitlock, J. M., de Castro, L. F., Collins, M. T., Chernomordik, L., & Boyce, A. M. (2023) · iScience · doi:10.1016/j.isci.2023.106470 · Cited by 7
Liuzzi, F., Taggi, M., Carlini, S. D., & Marca, A. L. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2276163 · Cited by 6
“An imbalance in the bone remodeling process due to excessive activity of osteoclasts or impaired osteoblast activity/differentiation may lead to pathological conditions characterized by low bone mass or density [4].”
BackgroundBones and guts – Why the microbiome matters
Contino, K. F., Cook, K. L., & Shiozawa, Y. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100523 · Cited by 5
“Pathological bone remodeling, a process mediated through multiple coordinated signaling mechanisms and defined by a dysregulation of osteoblast/osteoclast balance, is a hallmark of other disorders of the bone, such as osteoporosis and Paget ’ s disease [25].”
BackgroundUnderstanding Osteoporosis: Pathophysiology, Risk Factors, Diagnosis, and Management
Ismail, M. (2024) · Advances in Aging Research · doi:10.4236/aar.2024.133003 · Cited by 5
Yizhong, B., Chen, F., Jin, W., Dai, J., Mao, G., & Song, B.-S. (2024) · Communications Biology · doi:10.1038/s42003-024-07097-2 · Cited by 5
Xiu, Z., Gao, Z., & Luo, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-10191-y · Cited by 5
Denosumab for treatment of breast cancer bone metastases and beyond
Nangia, J. R., JOSEPH, D. R., Nguyen, C. M., Mendes, M., & Trivedi, M. V. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.664634 · Cited by 6
“A detailed review on bone remodeling has been published elsewhere [50].”
BackgroundFujita, H., Hinoi, E., Watanabe, T., Iezaki, T., Takamori, M., Ogawa, S., & Yoneda, Y. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00893 · Cited by 5
Hinoi, E. (2012) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.132.721 · Cited by 5
Nishizono, S., Hata, H., Miyatake, M., Kobayashi, T., Matsubara, J., Ito, K., Tsuboi, M., Sakatani, Y., Yamaguchi, M., & Sameshima, H. (2019) · Food Science and Technology Research · doi:10.3136/fstr.25.569 · Cited by 5
“The imbalance between the regulation of osteoclast and osteoblast activities is known to result in certain metabolic bone diseases including osteoporosis (Feng and McDonald, 2011).”
BackgroundHioki, T., Kawabata, T., Sakai, G., Fujita, K., Kuroyanagi, G., Matsushima‐Nishiwaki, R., Kim, W. Y., Otsuka, T., Iida, H., Tokuda, H., et al. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1809987 · Cited by 5
Sarker, H., Hardy, E., Haimour, A., Karim, M. A., Scholl‐Bürgi, S., Martignetti, J. A., Botto, L. D., & Fernández-Patrón, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568718 · Cited by 6
Razaly, N. I., Mohammad, A., Shamsir, M., Nadia, M. E., & Mohd Dzulkhairi, M. R. (2020) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v18i1.231 · Cited by 6
Mašánová, V., Krivošíková, Z., Ursı́nyová, M., Uhnáková, I., Kebis, A., Kramárová, P., Wsólová, L., & Gajdos, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02655-9 · Cited by 5
Anderson, L. J., Migula, D., Abay, R., Crabtree, S., Graf, S. A., Matsumoto, A. M., Chauncey, T. R., & Garcia, J. M. (2021) · Andrology · doi:10.1111/andr.13117 · Cited by 5
Han, S., & Kim, Y.-K. (2021) · Molecules · doi:10.3390/molecules26247579 · Cited by 5
“Regulation of bone remodeling occurs by various mechanisms related to the interaction between osteoclasts and osteoblasts [7,8].”
BackgroundSundkvist, J., Möller, M., Rogmark, C., Wolf, O., & Mukka, S. (2022) · Acta Orthopaedica · doi:10.2340/17453674.2022.2460 · Cited by 5
“J Bone Joint Surg Am 2018; 100(17): 1496-1502.”
BackgroundGPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice
Chen, J., Lazarenko, O. P., & Blackburn, M. L. (2022) · Bone · doi:10.1016/j.bone.2022.116422 · Cited by 6
8-Nitro-cGMP suppresses mineralization by mouse osteoblasts
Kaneko, K. J., Miyamoto, Y., Ida, T., Morita, M., Yoshimura, K., Nagasaki, K., Toba, K., Sugisaki, R., Motohashi, H., Akaike, T., et al. (2022) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21-129 · Cited by 5
Jiang, X., Yan, N., Zheng, Y., Yang, J., & Zhao, Y. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-06014-0 · Cited by 5
“It leads to the imbalance of calcium and phosphorus metabolism in the human body and the gradual reduction of bone mineral density [27, 28].”
BackgroundWatanabe, A., Tsurui, K., Yoneyama, S., Iwata, H., Anzai, T., Jerome, C. P., & Nakae, D. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.435 · Cited by 5
“Use of these drugs may increase bone mineral density (BMD) or the amount of bone mass per unit volume and reduce bone fractures in the short term; however, they inhibit normal bone metabolism (Feng and McDonald, 2011; Iizuka and Matsukawa, 2008).”
Auditory ossicles: a potential biomarker for maternal and infant health in utero
Leskovar, T., Beaumont, J., Lisić, N., & McGalliard, S. (2019) · Annals of Human Biology · doi:10.1080/03014460.2019.1639824 · Cited by 5
“Due to constant remodelling, isotopic values of bone collagen represent an isotopic average of several years, depending on the skeletal element and age, sex and health of the individual (Hedges et al. 2007; Feng and McDonald 2011).”
BackgroundThe transcriptional modulator Ifrd1 is a negative regulator of BMP-2-dependent osteoblastogenesis
Onishi, Y., Park, G., Iezaki, T., Horie, T., Kanayama, T., Fukasawa, K., Ozaki, K., & Hinoi, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.063 · Cited by 6
Nasulewicz‐Goldeman, A., Goldeman, W., Mrówczyńska, E., & Wietrzyk, J. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13597 · Cited by 5
“Excessive bone resorption is observed in many diseases, such as Paget's disease, tumor‐induced osteolysis, and postmenopausal osteoporosis (Feng & McDonald, 2011).”
BackgroundMorgan, J. A. (2014) · Scholarship@Western (Western University) · Cited by 6
SUV39H1-dependent methyl-degron is a critical regulator of skeletal homeostasis
Li, Q., An, H., Bai, R., Sun, Q., Yang, R., Xin, T., Zhuang, Z., Lu, Y., Tang, Y., Chen, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115910 · Cited by 5
Mao, S., Xu, C., & Zou, L. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70432 · Cited by 4
Metadata
- Authors
- Feng, X., & McDonald, J. M.
- Affiliations
- University of Alabama at Birmingham (US)
- ORCID
- Feng, Xu
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 121-145
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- PMC
- PMC3571087
- OpenAlex
- W2166266977
- Cited by
- 1,272
- References
- 171
- Citations by year
- 2026: 59 · 2025: 109 · 2024: 102 · 2023: 124 · 2022: 135 · 2021: 142 · 2020: 107 · 2019: 117 · 2018: 86 · 2017: 68 · 2016: 59 · 2015: 47 · 2014: 36 · 2013: 37 · 2012: 29
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA109119)
- National Institute of Neurological Disorders and Stroke (R21NS061677, NS061677)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (5P30 AR0406031, R01AR047830, AR 47830, R01AR050235)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- bone remodeling, bone resorption, bone formation, osteoclasts, osteoblasts, bone disease, menopause, hormonal changes, age-related bone loss, physical activity, drug-induced bone loss, mineral homeostasis, pathophysiology
- MeSH terms
- Animals, Bone Diseases, Humans, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review